SAN FRANCISCO, May 13, 2022 – Hyfe, Inc., the global leader in AI-powered cough detection and classification, is continuing the expansion of its technology platform that enables medical professionals and researchers to track coughs to better identify and treat respiratory illnesses. Hyfe’s unique ability to unobtrusively recognize, quantify and characterize cough in real time at scale has the potential to improve the lives of patients, the quality of provider’s care, the efficiency of health systems and accelerate the development of new drugs.
Hyfe’s AI-powered technology passively and remotely monitors the number of times a person coughs and the sound of the cough through any smart device, such as a mobile phone. This longitudinal data collected over time provides greater and more reliable information than a single visit to the doctor by revealing patterns and correlations that might otherwise go unnoticed. In addition, Hyfe maintains the largest cough dataset in the world enabling the sound of a patient’s cough to be compared with more than 250 million cough like sounds from 83 countries across all continents.
“The pattern and acoustic characteristics of cough are critical factors in the diagnosis and management of medical conditions,” said Peter Small, M.D., chief medical officer of Hyfe, Inc. “Most people cannot correctly estimate the number of times they cough per day and artificial intelligence can detect nuances in sounds that cannot be heard by the human ear.” Small added that “cough frequency should be measured with the same accuracy as blood pressure, temperature, heartbeat and other biomarkers that are essential for assessing health and illness.”
Hyfe, Inc. is the global leader in AI-powered cough detection and classification that provides insight into cough patterns and correlations that can greatly improve treatment and prevention.
With more than 250 million samples, Hyfe maintains the largest cough dataset in the world enabling the building of powerful models to track, manage and diagnose respiratory illnesses. Hyfe provides platforms and data for pharmaceutical companies, medical researchers, health care providers and patients. The company was founded in 2020 and is headquartered in Wilmington, Delaware More information is available at hyfe.ai, on social media @hyfeapp and LinkedIn at /hyfe.
Q & A with Dr. Marc Judson
Leading sarcoidosis expert is exploring cough monitoring in pulmonary sarcoidosis to assess treatment efficacy, anticipating that cough improvement precedes other symptom relief, revolutionizing patient care
Acoustic AI Frameworks: Single-Sound Analysis vs. Continuous Cough Monitoring
Review of single-sound analysis vs. continuous cough monitoring in AcousticAI diagnostics. Highlights the latter's edge in scalability, accuracy, and patient compliance for advancing respiratory health.